Long-Term Tirzepatide Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF – Pharmacy Times

admin

  1. Long-Term Tirzepatide Demonstrates Benefits in Patients With CKD, Obesity, and HFpEF  Pharmacy Times
  2. KOL Views Q&A: Zepbound boosts CV outcomes in HFpEF patients regardless of kidney function  FirstWord Pharma
  3. Positive Results for Tirzepatide in Those With the Cardiovascular-Kidney-Metabolic Triad | ACC 2025  Managed Healthcare Executive
  4. ACC 25: tirzepatide influences clinical trajectory of patients with HFpEF and obesity  Yahoo Finance
  5. Tirzepatide improves outcomes in HFpEF, obesity regardless of kidney function  Healio

Source link
Related Articles
↑
Exit mobile version